⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ALNY News
Alnylam Pharmaceuticals, Inc.
Tenaya Therapeutics Enters into Research Collaboration with Alnylam Pharmaceuticals to Identify and Validate Novel Genetic Targets for Cardiovascular Disease Therapeutics
globenewswire.com
ALNY
TNYA
Global Orphan Drugs Market is Anticipated to Cross USD 350 Billion by 2032 | DelveInsight
prnewswire.com
BIIB
IONS
ALNY
AZN
GILD
JNJ
BMRN
VRTX
ASTL
PFE
NVO
REGN
Form 8-K
sec.gov
ALNY
Protego Biopharma Appoints John M. Maraganore, Ph.D., to Board of Directors
prnewswire.com
ALNY
BIIB
BEAM
Oligonucleotides Global Markets, 2022-2024 & 2025-2030, Profiles of Major Players - Alnylam Pharmaceuticals, Biogen/Ionis Pharmaceuticals, Novartis, and Sarepta Therapeutics
globenewswire.com
ALNY
SRPT
IONS
JAZZ
Alnylam to Webcast Presentation at TD Cowen 46 th Annual Health Care Conference
businesswire.com
ALNY
Drug-Delivery Breakthroughs, Cross-Indication Research Accelerate New Momentum in CNS and Oncology Development
globenewswire.com
WVE
ALNY
DNLI
RNA Interference Therapy Competitive Landscape Research 2026: Comprehensive Insights About 40+ Companies and 90+ Drugs - Collaborations, Acquisitions, and Licensing Deals
globenewswire.com
ALNY
REGN
U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs
globenewswire.com
BMY
GILD
JNJ
SNY
TAK
AMGN
AZN
LLY
MRK
PFE
REGN
VRTX
ABBV
ALNY
AMTX
BIIB
BMRN
CRSP
EXAS
INCY
IONS
JAZZ
NTLA
PTC
RGEN
XOM
Global Oligonucleotide Therapeutics Market Set to Surge to USD 17.70 Billion by 2030 | MarketsandMarkets™
globenewswire.com
BIIB
ALNY
SRPT